20-F Filing

RENALYTIX PLC CIK: 1811115 FY 2022

Filing Information

Form Type	20-F
Accession Number	`0000950170-22-020618`
Period End Date	20220630
Filing Date	20221031
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	rnlx-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 81 Cash Flow Statement 107 Stockholders Equity 25

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common stock par or stated value per share	`CommonStockParOrStatedValuePerShare`	$3.63	USD	Point-in-time
Common stock par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.00	GBP	Point-in-time
Common stock par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.00	GBP	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	79.32M	shares	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	79.32M	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	74.76M	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	2.43M	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	72.20M	shares	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	74.76M	shares	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	72.20M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$41.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$65.13M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$901.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$594.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.44M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$993.00K	USD	Point-in-time
Note receivable from Kantaro	`NotesReceivableRelatedPartiesCurrent`	$75.00K	USD	Point-in-time
Note receivable from Kantaro	`NotesReceivableRelatedPartiesCurrent`	$75.00K	USD	Point-in-time
Receivable from affiliates	`DueFromAffiliateCurrent`	$1.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$66.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.75M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.56M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.49M	USD	Point-in-time
Investment in VericiDx	`InvestmentsInAndAdvancesToAffiliatesAtFairValue`	$2.74M	USD	Point-in-time
Investment in VericiDx	`InvestmentsInAndAdvancesToAffiliatesAtFairValue`	$9.29M	USD	Point-in-time
Investment in Kantaro	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$9.00K	USD	Point-in-time
Total assets	`Assets`	$50.06M	USD	Point-in-time
Total assets	`Assets`	$78.58M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.38M	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$361.00K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$1.08M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$3.06M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$4.60M	USD	Point-in-time
Accrued expenses - related party	`AccruedExpensesRelatedPartyCurrent`	$1.50M	USD	Point-in-time
Accrued expenses - related party	`AccruedExpensesRelatedPartyCurrent`	$224.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$122.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$46.00K	USD	Point-in-time
Convertible notes-current	`ConvertibleNotesPayableCurrent`	$4.66M	USD	Point-in-time
Payable to affiliate - current	`DueToAffiliateCurrent`	$55.00K	USD	Point-in-time
Payable to affiliate - current	`DueToAffiliateCurrent`	$350.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.78M	USD	Point-in-time
Convertible notes-noncurrent	`ConvertibleLongTermNotesPayable`	$7.68M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$53.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$19.46M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.12M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, 0.0025 par value per share: 79,315,333 shares authorized; 74,760,432 and 72,197,286 shares issued and outstanding at June 30, 2022 and June 30, 2021, respectively	`CommonStockValue`	$228.00K	USD	Point-in-time
Ordinary shares, 0.0025 par value per share: 79,315,333 shares authorized; 74,760,432 and 72,197,286 shares issued and outstanding at June 30, 2022 and June 30, 2021, respectively	`CommonStockValue`	$220.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$164.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$150.41M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-915.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$8.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-132.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.44M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.55M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$71.46M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$15.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$30.61M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$50.06M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$78.58M	USD	Point-in-time

Income Statement 81 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$2.97M	USD	Annual
Revenue	`Revenues`	$1.49M	USD	Annual
Revenue	`Revenues`	-	USD	Annual
Cost of revenue	`CostOfRevenue`	-	USD	Annual
Cost of revenue	`CostOfRevenue`	$858.00K	USD	Annual
Cost of revenue	`CostOfRevenue`	$2.10M	USD	Annual
Gross profit	`GrossProfit`	$874.00K	USD	Annual
Gross profit	`GrossProfit`	$633.00K	USD	Annual
Gross profit	`GrossProfit`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$14.65M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$10.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.57M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$23.48M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.75M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$39.52M	USD	Annual
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	-	USD	Annual
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$970.00K	USD	Annual
Performance of contract liability to affiliate	`PerformanceOfContractLiabilityToAffiliate`	$115.00K	USD	Annual
Total operating expenses	`OperatingExpenses`	$54.06M	USD	Annual
Total operating expenses	`OperatingExpenses`	$10.31M	USD	Annual
Total operating expenses	`OperatingExpenses`	$32.55M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-53.18M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-31.92M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-10.31M	USD	Annual
Equity in net (losses) earnings of affiliate	`IncomeLossFromEquityMethodInvestments`	$9.00K	USD	Annual
Equity in net (losses) earnings of affiliate	`IncomeLossFromEquityMethodInvestments`	$-63.00K	USD	Annual
Equity in net (losses) earnings of affiliate	`IncomeLossFromEquityMethodInvestments`	$-2.11M	USD	Annual
Foreign currency gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$245.00K	USD	Annual
Foreign currency gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$-8.77M	USD	Annual
Foreign currency gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$9.69M	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	-	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$-6.48M	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.90M	USD	Annual
Fair value adjustment to Convertible notes	`FairValueAdjustmentToConvertibleNotes`	$-4.00M	USD	Annual
Fair value adjustment to Convertible notes	`FairValueAdjustmentToConvertibleNotes`	-	USD	Annual
Fair value adjustment to Convertible notes	`FairValueAdjustmentToConvertibleNotes`	-	USD	Annual
Other income, net	`OtherNonoperatingIncome`	$289.00K	USD	Annual
Other income, net	`OtherNonoperatingIncome`	$131.00K	USD	Annual
Other income, net	`OtherNonoperatingIncome`	$981.00K	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.84M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.34M	USD	Annual
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-45.25M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$25.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-35.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.84M	USD	Annual
Net loss	`NetIncomeLoss`	$-45.28M	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$611.00K	USD	Annual
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.84M	USD	Annual
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-34.73M	USD	Annual
Net loss attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-45.28M	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.62	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.49	USD	Annual
Earnings Per Share, Basic	`EarningsPerShareBasic`	$-0.17	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.17	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.67	USD	Annual
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$-0.49	USD	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	59.08M	shares	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	71.48M	shares	Annual
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	72.86M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	59.08M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	71.48M	shares	Annual
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	73.84M	shares	Annual
Changes in the fair value of the convertible notes	`ChangesInFairValueOfConvertibleNotes`	-	USD	Annual
Changes in the fair value of the convertible notes	`ChangesInFairValueOfConvertibleNotes`	-	USD	Annual
Changes in the fair value of the convertible notes	`ChangesInFairValueOfConvertibleNotes`	$536.00K	USD	Annual
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-378.00K	USD	Annual
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.73M	USD	Annual
Foreign exchange translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$9.50M	USD	Annual
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-54.47M	USD	Annual
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-25.84M	USD	Annual
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-10.22M	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-72.00K	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-54.47M	USD	Annual
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-25.76M	USD	Annual
Comprehensive loss attributable to Renalytix	`ComprehensiveIncomeNetOfTax`	$-10.22M	USD	Annual

Cash Flow Statement 107 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-35.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.84M	USD	Annual
Net loss	`NetIncomeLoss`	$-45.28M	USD	Annual
Gain on VericiDx deconsolidation	`DeconsolidationGainOrLossAmount`	$46.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$70.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$489.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$282.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.66M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.16M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$4.62M	USD	Annual
Gain on loan	`GainLossOnSalesOfLoansNet`	$255.00K	USD	Annual
Realized gain on short-term investments	`DebtAndEquitySecuritiesRealizedGainLoss`	$128.00K	USD	Annual
Realized gain on short-term investments	`DebtAndEquitySecuritiesRealizedGainLoss`	$18.00K	USD	Annual
Equity in (net earnings) losses of affiliate	`IncomeLossFromEquityMethodInvestments`	$9.00K	USD	Annual
Equity in (net earnings) losses of affiliate	`IncomeLossFromEquityMethodInvestments`	$-63.00K	USD	Annual
Equity in (net earnings) losses of affiliate	`IncomeLossFromEquityMethodInvestments`	$-2.11M	USD	Annual
Reduction of Kantaro Liability	`ReversalOfKantaroLiability`	$119.00K	USD	Annual
Reduction of Kantaro Liability	`ReversalOfKantaroLiability`	$495.00K	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	-	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$-6.48M	USD	Annual
Fair value adjustment to VericiDx investment	`FairValueAdjustmentToVericidxInvestment`	$5.90M	USD	Annual
Unrealized foreign exchange (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$213.00K	USD	Annual
Unrealized foreign exchange (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$7.34M	USD	Annual
Unrealized foreign exchange (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-5.54M	USD	Annual
Fair value adjustment to convertible Debt	`FairValueAdjustmentToConvertibleNotes`	$-4.00M	USD	Annual
Fair value adjustment to convertible Debt	`FairValueAdjustmentToConvertibleNotes`	-	USD	Annual
Fair value adjustment to convertible Debt	`FairValueAdjustmentToConvertibleNotes`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$307.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$594.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$325.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.49M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$710.00K	USD	Annual
Receivable from affiliates	`IncreaseDecreaseInDueFromAffiliatesCurrent`	$-1.00K	USD	Annual
Receivable from affiliates	`IncreaseDecreaseInDueFromAffiliatesCurrent`	$18.00K	USD	Annual
Receivable from affiliates	`IncreaseDecreaseInDueFromAffiliatesCurrent`	$-17.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.42M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$355.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$782.00K	USD	Annual
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParty`	$722.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-1.50M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-456.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.35M	USD	Annual
Accrued expenses - related party	`IncreaseDecreaseInAccruedExpensesRelatedParty`	$585.00K	USD	Annual
Accrued expenses - related party	`IncreaseDecreaseInAccruedExpensesRelatedParty`	$1.27M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$122.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-76.00K	USD	Annual
Payable to affiliate - current	`IncreaseDecreaseInDueToAffiliates`	$-176.00K	USD	Annual
Payable to affiliate - current	`IncreaseDecreaseInDueToAffiliates`	$-185.00K	USD	Annual
Payable to affiliate - current	`IncreaseDecreaseInDueToAffiliates`	$-970.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$53.00K	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-53.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.92M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.40M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.52M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$773.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$557.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$804.00K	USD	Annual
Software development costs	`PaymentsToDevelopSoftware`	$749.00K	USD	Annual
Software development costs	`PaymentsToDevelopSoftware`	$427.00K	USD	Annual
Software development costs	`PaymentsToDevelopSoftware`	$105.00K	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$21.26M	USD	Annual
Proceeds from short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$1.00M	USD	Annual
Proceeds from short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$21.40M	USD	Annual
Note receivable-related party	`IncreaseDecreaseInNotesReceivableRelatedParties`	$-83.00K	USD	Annual
Note receivable-related party	`IncreaseDecreaseInNotesReceivableRelatedParties`	$-167.00K	USD	Annual
Decrease in cash (VericiDx deconsolidation)	`CashDivestedFromDeconsolidation`	$62.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-662.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.17M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-751.00K	USD	Annual
Procceds from convertible notes	`ProceedsFromConvertibleDebt`	$18.02M	USD	Annual
Gross proceeds from the issuance of ordinary shares, net of underwriting fees	`GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees`	-	USD	Annual
Gross proceeds from the issuance of ordinary shares, net of underwriting fees	`GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees`	$79.18M	USD	Annual
Gross proceeds from the issuance of ordinary shares	`ProceedsFromIssuanceOfCommonStock`	$17.28M	USD	Annual
Gross proceeds from the issuance of ordinary shares	`ProceedsFromIssuanceOfCommonStock`	$8.80M	USD	Annual
Payment of offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$218.00K	USD	Annual
Payment of offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$1.59M	USD	Annual
Payment of offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$2.31M	USD	Annual
Proceeds from the issuance of ordinary shares under employee share purchase plan	`ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan`	$209.00K	USD	Annual
Proceeds from the issuance of ordinary shares under employee share purchase plan	`ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan`	$111.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$197.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$252.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts1`	$1.38M	USD	Annual
Proceeds from PPP Loan	`ProceedsFromIssuanceOfOtherLongTermDebt`	$255.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$77.24M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.94M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.63M	USD	Annual
Effect of exchange rate changes on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$3.75M	USD	Annual
Effect of exchange rate changes on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.84M	USD	Annual
Effect of exchange rate changes on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-150.00K	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.09M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$51.84M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-23.80M	USD	Annual
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.20M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.13M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.29M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$41.33M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.20M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.13M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.29M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$41.33M	USD	Point-in-time
Financing costs in accounts payable and accrued expenses	`DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$1.63M	USD	Annual
Reclassification of note receivable in Kantaro to Investment in Kantaro	`ReclassificationOfNoteReceivableInKantaroToInvestmentInKantaro`	$175.00K	USD	Annual
Deemed distribution of VericiDx ordinary shares	`DeemedDistributionOfOrdinarySharesNonCashTransaction`	$75.00K	USD	Annual
Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares	`ConversionOfNotesReceivableIntoOrdinaryShares`	$2.56M	USD	Annual
Software development costs in accounts payable and accrued expenses	`SoftwareDevelopmentCostsIncurredButNotPaid`	$177.00K	USD	Annual
Purchase of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$56.00K	USD	Annual
Fair value of services exchanged for equity method investment of which services are recorded as the payable to affiliate	`FairValueOfServicesExchangedForEquityMethodInvestment`	$2.00M	USD	Annual

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$8.55M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$71.46M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$15.91M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$30.61M	USD	Point-in-time
Deconsolidation of Verici	`NoncontrollingInterestDecreaseFromDeconsolidation`	$2.30M	USD	Annual
Shares issued under the Securities Purchase Agreement (Value)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$8.59M	USD	Annual
Shares issued under the employee share purchase plan (Value)	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$209.00K	USD	Annual
Shares issued under the employee share purchase plan (Value)	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$111.00K	USD	Annual
Exercise of stock options (Value)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$197.00K	USD	Annual
Exercise of stock options (Value)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$252.00K	USD	Annual
Exercise of stock options (Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	100,724.00	shares	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$4.62M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.16M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.66M	USD	Annual
Changes in the fair value of the convertible notes	`ChangesInTheFairValueOfTheConvertibleNotes`	$536.00K	USD	Annual
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$9.43M	USD	Annual
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.73M	USD	Annual
Currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-378.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-35.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.84M	USD	Annual
Net loss	`NetIncomeLoss`	$-45.28M	USD	Annual
Ending balance	`StockholdersEquity`	$8.55M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$71.46M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$15.91M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$30.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.